Skip to main content
66°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Organon & Co.
< Previous
1
2
Next >
Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
December 12, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at the Piper Sandler 34th Annual Healthcare Conference
November 15, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the Third Quarter Ended September 30, 2022
November 03, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022
October 20, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
August 17, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the Second Quarter Ended June 30, 2022
August 04, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon and Cirqle Biomedical Enter Research Collaboration and License Agreement for Investigational Non-hormonal, On-demand Contraceptive Candidate
July 28, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report Second Quarter Results and Host Conference Call on August 4, 2022
July 21, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates
June 13, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report
June 02, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the First Quarter Ended March 31, 2022
May 05, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
April 21, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
March 31, 2022
From
Organon & Co.
Via
Business Wire
Tickers
DARE
OGN
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021
February 17, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in Vietnam
February 16, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Declares Paid Time Off for All Employees on International Women’s Day; Employees to Focus on Their Own Health in Recognition of Growing Women’s Health Inequity
February 02, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022
February 01, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
FDA Accepts Samsung Bioepis’ and Organon’s sBLA for their Citrate-Free, High-Concentration HUMIRA® (Adalimumab) Biosimilar Candidate
January 05, 2022
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at the 40th Annual J.P. Morgan Healthcare Virtual Conference
December 20, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Completes Acquisition of Forendo Pharma
December 13, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at the Evercore ISI 4th Annual HealthCONx Conference
November 22, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the Third Quarter Ended September 30, 2021
November 11, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon to Acquire Forendo Pharma
November 11, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Report Third Quarter Results and Host Conference Call on November 11, 2021
October 28, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Launches New Fertility Journey Website as Part of Ongoing Commitment to Help Address the Needs of Women
October 15, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Receives FDA Clearance for Technological Updates to the Jada® System, a Medical Device Intended to Control Postpartum Hemorrhage
October 11, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Aims to Ignite Worldwide Conversation Around Unplanned Pregnancy
September 21, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference
September 01, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference
September 01, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
Organon Reports Results for the Second Quarter Ended June 30, 2021 and Announces Inaugural Dividend
August 12, 2021
From
Organon & Co.
Via
Business Wire
Tickers
OGN
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.